Production (Stage)
Trinity Biotech plc
TRIB
$0.64
$0.00590.93%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | 41.43% | 11.18% | -308.36% |
| Total Depreciation and Amortization | -- | -- | -22.62% | -3.48% | -34.30% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -65.67% | -47.47% | 49.89% |
| Change in Net Operating Assets | -- | -- | -62.13% | 44.56% | -288.38% |
| Cash from Operations | -- | -- | -1,158.93% | -730.49% | -92.69% |
| Capital Expenditure | -- | -- | 27.07% | 14.05% | -150.46% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 41.20% | 52.80% | 49.93% |
| Cash from Investing | -- | -- | 514.19% | 435.06% | 25.74% |
| Total Debt Issued | -- | -- | -95.00% | -95.00% | 5,569.78% |
| Total Debt Repaid | -- | -- | 90.03% | 90.00% | -3,934.90% |
| Issuance of Common Stock | -- | -- | -- | -98.48% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 36.78% | 43.77% | -433.43% |
| Cash from Financing | -- | -- | -30.21% | -8.12% | -245.58% |
| Foreign Exchange rate Adjustments | -- | -- | 62.39% | 764.71% | 115.32% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 85.07% | 95.09% | -367.26% |